Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Welcome to DarshanTalks!
We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!
Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do.
We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.
| Episode | Date |
|---|---|
|
Unlicensed Medical Advice & The Legal Battle Over Character.AI
|
May 18, 2026 |
|
Sponsoring Cannabis Research
|
May 06, 2026 |
|
The New Era of Personal Consent Decrees
|
Apr 30, 2026 |
|
Why Private Membership Associations Fail FDA Scrutiny
|
Apr 16, 2026 |
|
The Hidden Reason Sites are Firing Recruiters
|
Apr 11, 2026 |
|
Don’t Let Your PI Walk Away With Your Study
|
Apr 10, 2026 |
|
Safe or Just "Not Dirty"? The Regulatory Gamble of Compounded Drugs
|
Apr 09, 2026 |
|
"Basically Employees" Isn't a Legal Category (And the OIG Knows It)
|
Apr 06, 2026 |
|
The Hidden Legal Risks of AI Sponsor Protocols
|
Apr 03, 2026 |
|
The $100M Mistake: Why AI-Generated Drugs May Not Be Patentable
|
Apr 02, 2026 |
|
Is AI replacing your Doctor?
|
Mar 30, 2026 |
|
Why the OIG Just Revolutionized Pharma Marketing (And What It Costs You)
|
Mar 28, 2026 |
|
6 Categories of "Bulk Data" That Could Land You in Federal Court.
|
Mar 27, 2026 |
|
The Utah Experiment: The Dangerous New Frontier of AI Prescribing
|
Mar 26, 2026 |
|
Is Your DTC Program a Kickback Trap?
|
Mar 23, 2026 |
|
The Hidden Death Sentence for Trial Sites
|
Mar 20, 2026 |
|
FDA "Screams": The Real Reason Your Snack Is At Risk
|
Mar 19, 2026 |
|
2 Laws More Dangerous Than HIPAA for Patient Engagement
|
Mar 16, 2026 |
|
"Invite-Only" Compliance Is Over: Is Your Cosmetic Company Ready?
|
Mar 14, 2026 |
|
Audit-Proof Your Site: The Training Gap Killing Your Contracts
|
Mar 13, 2026 |
|
15 Years in Prison for Marketing Fraud
|
Mar 12, 2026 |
|
Is your "Clinical Decision Support" tool actually an unregulated medical device?
|
Mar 11, 2026 |
|
The FDA’s New Political Enforcement Strategy
|
Mar 10, 2026 |
|
Why Your "Physician-Only" Ads Aren't Safe from Regulators
|
Mar 09, 2026 |
|
The Messy Reality of AI Prescriptions
|
Mar 08, 2026 |
|
Why Your Consultant’s Report Is a Legal Liability
|
Mar 07, 2026 |
|
Stop Reporting Results? The NIH’s "Get Out of Jail Free" Card
|
Mar 06, 2026 |
|
Final LGBTQ Individuals in clinical research
|
Mar 05, 2026 |
|
When the FDA Plays Politics
|
Mar 04, 2026 |
|
Your Site’s Background Check is Illegally Incomplete - Here is why
|
Mar 03, 2026 |
|
Is Your Off-Label Use Now a Federal Crime?
|
Mar 02, 2026 |
|
10,000 Specialists: A Futurist’s Vision for AI Healthcare
|
Feb 23, 2026 |
|
The Battle Over Weight Loss and Compounded Drugs
|
Feb 16, 2026 |
|
Why Cosmetic Ingredient Names Matter and What MOCRA Really Means - Interview with Heather Bustos
|
Jan 29, 2026 |
|
Compliance Isn’t a Deal Killer… Until It Is - Interview with Stephanie Trunk
|
Jan 22, 2026 |
|
Cosmetic ingredients the FDA doesn’t want you to use
|
Jan 17, 2026 |
|
Why Federal Agencies Are Targeting Executives
|
Jan 15, 2026 |
|
Why the New Food Pyramid Matters to You
|
Jan 10, 2026 |
|
Ex FDA Commissioner Robert Califf on FDA Authority, Politics, and the Health Crisis No One Wants to Name
|
Jan 08, 2026 |
|
Buying a Med Spa? GLP-1 Compliance Can Kill the Deal
|
Jan 08, 2026 |
|
New crown jewel valuing patient data
|
Jan 02, 2026 |
|
Your Staff is trained, but can you prove it?
|
Dec 26, 2025 |
|
What Happens When a Sponsor Walks Away Early?
|
Dec 23, 2025 |
|
Cosmetic Claims the FDA Hates
|
Dec 22, 2025 |
|
Biggest Legal Mistakes in Influencer Marketing
|
Dec 18, 2025 |
|
Your Mood, Energy, and Sleep Claims Might Be Regulated
|
Dec 11, 2025 |
|
Device Fail: The Legal Anatomy of a Faulty Implant Scandal
|
Dec 10, 2025 |
|
5 Documents the FDA Will Demand on Site — Are You Ready?
|
Dec 09, 2025 |
|
Cosmetic Marketing Mistakes That Trigger Regulators
|
Dec 04, 2025 |
|
Why Your Clinical Trial Contract Is Leaving Cash on the Table
|
Dec 02, 2025 |
|
Why Testimonials Can Get Your Brand Sued
|
Nov 29, 2025 |
|
How to Get Sponsors to Pay Faster than Net 90
|
Nov 27, 2025 |
|
Compliance Mistakes That Kill Pharma and Biotech Deals
|
Nov 14, 2025 |
|
Balance FDA Rules with FTC Advertising Requirements
|
Nov 12, 2025 |
|
Key Clauses in PI Contracts to Review
|
Nov 10, 2025 |
|
Compliance guru talks practical Insights on Speaker Programs
|
Nov 07, 2025 |
|
Trends in Small Life Sciences Transactions
|
Nov 05, 2025 |
|
Protect Your Site If a Sponsor Terminates Early
|
Nov 03, 2025 |
|
Are Pharma Chatbots Putting You at Regulatory Risk?
|
Nov 01, 2025 |
|
Are Your Cosmetic Company Records Ready for FDA Audits?
|
Oct 30, 2025 |
|
When Medical Affairs Becomes Commercial in Disguise
|
Oct 24, 2025 |
|
Serious Adverse Event Reporting Under MoCRA
|
Oct 22, 2025 |
|
Key SOPs for Clinical Trials
|
Oct 20, 2025 |
|
Payer Presentations Can Trigger Enforcement
|
Oct 18, 2025 |
|
Pharmacies v manufacturers
|
Oct 16, 2025 |
|
Is Clinical Research Ready for the new FDA?
|
Oct 13, 2025 |
|
Is your cosmetics company FDA-registered?
|
Oct 11, 2025 |
|
Will AI Replace Doctors in clinical research?
|
Oct 09, 2025 |
|
Risks in Direct-to-Patient Engagement
|
Oct 07, 2025 |
|
Inside 340B: Challenges, Controversies, and Opportunities
|
Oct 01, 2025 |
|
IRBs in 2025: What’s Really Changing?
|
Sep 27, 2025 |
|
3 Red Flags in Telemedicine Partnerships
|
Sep 25, 2025 |
|
What do PBMs do?
|
Sep 21, 2025 |
|
How AMCs Build Stronger Compliance Cultures Together
|
Sep 19, 2025 |
|
How One DME Scheme Cost Medicare $61 Million
|
Sep 15, 2025 |
|
FDA to Step Up Enforcement on Pharma Advertising
|
Sep 12, 2025 |
|
Top 5 Factors Determining AMC Funding
|
Sep 09, 2025 |
|
New Series Drop: Exploring AMCs in Clinical Research
|
Sep 06, 2025 |
|
Why Choose a Licensed Attorney Over a Consultant?
|
Sep 04, 2025 |
|
Marketing Problems by Hims & Hers and Lilly
|
Sep 02, 2025 |
|
Should Sponsors Share Site Feedback?
|
Aug 29, 2025 |
|
AI Marketing Playbook for Drug Companies
|
Aug 26, 2025 |
|
Should Sites Be Ready on Standby?
|
Aug 23, 2025 |
|
Eastern District of PA Targets Pharmacies
|
Aug 21, 2025 |
|
Telehealth Done Right
|
Aug 18, 2025 |
|
DOJ and HHS Launch FCA Fraud Task Force
|
Aug 15, 2025 |
|
Should Sponsors Cover Malpractice Insurance?
|
Aug 13, 2025 |
|
Instagram Post that Sparked FDA Warning Letter
|
Aug 11, 2025 |
|
Why Are So Many Doctors Getting Arrested?
|
Aug 09, 2025 |
|
How to Run Compliant Pharma Speaker Programs
|
Aug 06, 2025 |
|
Are You Picking the Wrong KOLs?
|
Aug 04, 2025 |
|
How KLF’s Client Base Evolved Over 20 Years
|
Aug 02, 2025 |
|
FDA Pushback on Accelerated Gene Therapy Approvals
|
Jul 31, 2025 |
|
Your DEI Program Could Trigger an FCA Case
|
Jul 30, 2025 |
|
Teva’s Charity Partnership Scrutinized
|
Jul 28, 2025 |
|
Is There a “Right” Way to Calculate FMV?
|
Jul 25, 2025 |
|
Can Non-Physicians Own Clinical Trial Sites?
|
Jul 23, 2025 |
|
The KLF Story You Haven’t Heard
|
Jul 20, 2025 |
|
Why Telehealth Platforms Are Getting Sued
|
Jul 17, 2025 |
|
Should Clinical Trial Sites Be Paid Differently?
|
Jul 15, 2025 |
|
How to Build an AI Compliance Program
|
Jul 14, 2025 |
|
What the Big Beautiful Bill Means for Trial Sites
|
Jul 11, 2025 |
|
Co-Pay Mistakes Can Trigger DOJ Action
|
Jul 09, 2025 |
|
NIH Grant Denials Ruled Discriminatory?
|
Jul 08, 2025 |
|
Are Speaker programs supposed to be salesy?
|
Jul 04, 2025 |
|
DTP Compliance Just Got Tricky
|
Jun 28, 2025 |
|
Should You Use AI to Draft Informed Consent?
|
Jun 26, 2025 |
|
Could You Survive a Surprise Pharmacy Audit?
|
Jun 23, 2025 |
|
Self-Reporting in Clinical Trials
|
Jun 20, 2025 |
|
$14M Fine Says This “Free” Offer Wasn’t Legal
|
Jun 18, 2025 |
|
Nonprofit Pharma Exists. Here is how it works
|
Jun 16, 2025 |
|
FTC Rules for Pharma Companies
|
Jun 14, 2025 |
|
Whistleblowing in Clinical Trials: Is It Worth the Risk?
|
Jun 12, 2025 |
|
The Right Way to Do Medical Affairs on LinkedIn
|
Jun 09, 2025 |
|
Are We Paying Clinical Trial Patients Enough?
|
Jun 07, 2025 |
|
Pharma Ads Are Getting Canceled
|
Jun 04, 2025 |
|
Unpacking Screen Fail Payments in Research
|
May 31, 2025 |
|
Post-Trump Antitrust Rules Are Crushing Pharma Deals
|
May 28, 2025 |
|
7 Must-Know Steps to transfer medical device ownership
|
May 24, 2025 |
|
Responding to Site Findings
|
May 22, 2025 |
|
Is Your Medical Website Illegal?
|
May 20, 2025 |
|
Price Fixing in Clinical Research
|
May 17, 2025 |
|
DOJ Cracks Down on Pharmacy Fraud
|
May 15, 2025 |
|
Protect Your DTP Strategy
|
May 13, 2025 |
|
AI Clinical Trial Negotiators
|
May 10, 2025 |
|
SOPs: How Many is Too Many?
|
May 09, 2025 |
|
Is DTP Pharma’s Next Big Move?
|
May 07, 2025 |
|
Hackers Are Stealing Your Personal Health Data
|
May 05, 2025 |
|
How a “Medical Education” Program Became a $202M Fraud
|
May 03, 2025 |
|
Webinar Recap: What Sponsors Must Know About Fraud
|
May 01, 2025 |
|
AI-Powered Engagement is a Minefield
|
Apr 29, 2025 |
|
Webinar Update: Fraud Prevention Strategies Every Sponsor Needs
|
Apr 24, 2025 |
|
Are Your Promotional Claims Putting Your Company at Risk?
|
Apr 23, 2025 |
|
Privacy Dangers Lurking in Clinical Trial Mergers
|
Apr 21, 2025 |
|
The FDA's Crisis Is Now Your Problem
|
Apr 18, 2025 |
|
Broken FDA, Big Consequences
|
Apr 16, 2025 |
|
You are now the Healthcare Provider - The Future of Health Insurance: Trends, Challenges, and Innovations
|
Apr 14, 2025 |
|
Essential Due Diligence Steps for Clinical Research M&A
|
Apr 12, 2025 |
|
Is AI Telemarketing Strategy Illegal?
|
Apr 10, 2025 |
|
No Clinical Trial Waste
|
Apr 08, 2025 |
|
The Real Meaning of Audit-Readiness in Clinical Research
|
Apr 06, 2025 |
|
Ordinary People Are Changing Medicine
|
Apr 04, 2025 |
|
Investor Influence Can Trigger FCA Violations
|
Apr 02, 2025 |
|
Sponsor to Organization vs. Direct Investigator Agreements: Pros & Cons
|
Mar 31, 2025 |
|
Clinical Trial Site M&A: What Most Get Wrong
|
Mar 29, 2025 |
|
Future-Proof Sites: SOS Insights Revealed
|
Mar 27, 2025 |
|
Why Food M&A Deals Collapse—And How to Prevent It
|
Mar 25, 2025 |
|
Non-Compliance Led to QOL Medical's $47M Settlement
|
Mar 23, 2025 |
|
FDA Regulatory Submissions: Challenges, Trends, and Future Predictions
|
Mar 21, 2025 |
|
How to do a VR promo check - Carly Schaecter gives us her advice
|
Mar 19, 2025 |
|
Diversity Matters in Clinical Trials
|
Mar 18, 2025 |
|
EMA’s LLM Guidelines Impact Life Sciences
|
Mar 16, 2025 |
|
How to Network Like a Pro at Conferences
|
Mar 12, 2025 |
|
Getting Ready for SOS 2025: FDA 483s, SOPs, and Site Survival
|
Mar 10, 2025 |
|
Maximizing Site Value
|
Mar 07, 2025 |
|
5 Key Areas to Review in Clinical Trial Agreements
|
Mar 05, 2025 |
|
Discussing Stem Cell Research Opportunities with a Research Site Owner
|
Mar 03, 2025 |
|
Quality Management: A Must in Clinical Trial Contracts
|
Mar 01, 2025 |
|
AI-Powered Chatbots in Pharma Sales and Education
|
Feb 27, 2025 |
|
Will New Tariffs Disrupt Your Next Pharma Deal?
|
Feb 26, 2025 |
|
Protecting Patient Data in a Changing Regulatory Landscape
|
Feb 25, 2025 |
|
Off-Label Promotion Changes in 2025
|
Feb 24, 2025 |
|
Turning Physicians into Leaders
|
Feb 21, 2025 |
|
Key Regulatory Agencies in Pharma M&A
|
Feb 20, 2025 |
|
Does E6 (R3) Blur the Line Between GCP and Privacy Laws?
|
Feb 19, 2025 |
|
RFK Jr. Confirmed as HHS Secretary: What It Means for Healthcare Policy
|
Feb 18, 2025 |
|
America’s Research Future in Jeopardy
|
Feb 15, 2025 |
|
Trump Administration’s NIH cuts: Will they cripple US medical research?
|
Feb 14, 2025 |
|
DEI Under Trump: What It Means for Clinical Trials
|
Feb 13, 2025 |
|
CAPA & RCA: A Must for Pharma M&A
|
Feb 12, 2025 |
|
Trump Targets Indirect Costs in NIH Funding
|
Feb 11, 2025 |
|
The USAID Halt and Its Consequences for Clinical Research
|
Feb 10, 2025 |
|
Ebola Vaccine Trial in Record Time!
|
Feb 08, 2025 |
|
Your Clinical Trial Site M&A Agreement is Exposing You to Risk
|
Feb 07, 2025 |
|
What Does ICH E6 R3 Say About Returning Data to Participants?
|
Feb 05, 2025 |
|
Navigating the Ongoing HHS Communication Freeze
|
Feb 04, 2025 |
|
Ordinary People Are Changing Medicine
|
Feb 03, 2025 |
|
Trump’s First 10 Days: The Impact on Clinical Trials
|
Jan 31, 2025 |
|
Selling a Business with Issues
|
Jan 31, 2025 |
|
Breaking Down GCP E6(R3)
|
Jan 28, 2025 |
|
AdvaMed 7 rules for Essential AI Innovation
|
Jan 25, 2025 |
|
Teva’s Case Should Shape Your Pharma Strategy
|
Jan 22, 2025 |
|
AI’s Impact on Healthcare: Liability, Ethics, and Responsibility
|
Jan 21, 2025 |
|
Four Types of Research related Grant Fraud
|
Jan 18, 2025 |
|
Defining Scope in Due Diligence Transactions
|
Jan 17, 2025 |
|
Clinical Trial Checklist
|
Jan 16, 2025 |
|
Presidential Changes and Impact on Drug Related Misinformation
|
Jan 14, 2025 |
|
Prep for Selling Your Company!
|
Jan 12, 2025 |
|
Top Tips for Starting a Clinical Trial Site
|
Jan 10, 2025 |
|
When Drug Reps Visit: Darshan Reacts
|
Jan 09, 2025 |
|
Is Pfizer competing with your pharmacy?
|
Jan 08, 2025 |
|
Talking to a Functional Medicine Doctor
|
Jan 07, 2025 |
|
Four Types of Research related Grant Fraud
|
Jan 05, 2025 |
|
Leveraging AI and RWD to Reshape Drug Trials!
|
Jan 03, 2025 |
|
DCTs in Oncology: Can They Work?
|
Jan 01, 2025 |
|
Marketing Due Diligence in Stem cell M&A Transactions
|
Dec 31, 2024 |
|
Why Are PBMs Blocking Your Meds? - Darshan reacts
|
Dec 30, 2024 |
|
Misleading Ads: Ad laws and Consumer Protection for Marketers
|
Dec 28, 2024 |
|
5 Common Clinical Trial Site Failures
|
Dec 26, 2024 |
|
Faster FDA Recalls
|
Dec 24, 2024 |
|
IRB Challenges and Updates for 2024
|
Dec 23, 2024 |
|
Is the Polio Vaccine Safe?
|
Dec 22, 2024 |
|
FDA blue print to discuss off label topics
|
Dec 20, 2024 |
|
Opportunities AI provides in Clinical Research
|
Dec 18, 2024 |
|
Telehealth and Biohacking: A Risky Combination
|
Dec 16, 2024 |
|
Is the FDA’s Response to AI Falling Behind?
|
Dec 14, 2024 |
|
Healthcare Is in Crisis: How do we fix it?
|
Dec 13, 2024 |
|
Will RFK Break Pharma?
|
Dec 12, 2024 |
|
Fake data in Clinical Trials
|
Dec 10, 2024 |
|
Darshan Fixes Big Pharma Misconceptions
|
Dec 08, 2024 |
|
How Trump’s Tariffs will Disrupt Clinical Trials and Drug Marketing?
|
Dec 06, 2024 |
|
Why China is Targeting Top Scientists!
|
Dec 04, 2024 |
|
Trump’s Bold Picks Shake Up Life Sciences
|
Dec 02, 2024 |
|
3 Regulatory Opportunities in Clinical Trials!
|
Nov 30, 2024 |
|
Don't Take Non-Prescription Ozempic or other Weight Loss Drugs
|
Nov 28, 2024 |
|
Clinical Trial Principal Investigator Duties in Clinical Trials
|
Nov 26, 2024 |
|
Supreme Court Redefined Pharma Marketing Rules
|
Nov 23, 2024 |
|
AI concerns in M&A for Life Sciences
|
Nov 20, 2024 |
|
Trump Teams Potential Changes to Healthcare
|
Nov 19, 2024 |
|
Can AI Rewrite the Rules of Clinical Trials?
|
Nov 18, 2024 |
|
Ad Promo Review in Pharma - How Far is Too Far?
|
Nov 16, 2024 |
|
Why Staff Training Problems are a liability for Your Clinical Trial site
|
Nov 14, 2024 |
|
Neuralink: Breakthrough or Marketing Hype?
|
Nov 12, 2024 |
|
Telehealth Compliance Crisis: DOJ exposes $2.75B Fraud!
|
Nov 09, 2024 |
|
Should You Go In-House or Outsource Your Advertising Compliance?
|
Nov 06, 2024 |
|
Research fraud tainting pharma per Nature Article
|
Nov 04, 2024 |
|
Influencers are NOT KOLs. Know your Needs!
|
Oct 31, 2024 |
|
AI and Clinical Trials: Faster Results, Bigger Risks?
|
Oct 28, 2024 |
|
Eli Lilly’s Unexpected Shift on Use of Mounjaro!
|
Oct 25, 2024 |
|
Are CROs Losing Relevance in the Age of DCTs?
|
Oct 23, 2024 |
|
Managing Risks in Life Science Mergers and Acquisitions with Strategic Insurance
|
Oct 19, 2024 |
|
Can a Pharmacist Override Your Doctor's Prescription?
|
Oct 17, 2024 |
|
FDA Concerns About AI’s impact on Good Clinical Practices
|
Oct 15, 2024 |
|
Patient Advocates Could Cost You Millions
|
Oct 11, 2024 |
|
Managing Risks in Life Sciences Mergers and Acquisitions
|
Oct 08, 2024 |
|
How do pharmacists’ read doctors’ cursive letters?
|
Oct 06, 2024 |
|
AI Data Ownership in Pharma
|
Oct 03, 2024 |
|
Role of Tech Transfer in Clinical trial agreements
|
Sep 30, 2024 |
|
Why are medicine names so complicated?
|
Sep 22, 2024 |
|
Fixing Congruency Reviews in 8 Minutes
|
Sep 21, 2024 |
|
The Dark Side of Med Device Kickbacks
|
Sep 17, 2024 |
|
Which Hair Loss Treatment Is Right for You?
|
Sep 14, 2024 |
|
Analyzing the Publication Rights Clause in CTAs
|
Sep 09, 2024 |
|
What Really Starts Pharmacy Investigations?
|
Sep 07, 2024 |
|
Is your clinical trial AI racist?
|
Aug 20, 2024 |
|
Another Pharmacy owner Jailed in Fraud Case
|
Aug 17, 2024 |
|
Navigating FDA's clinical trial expectations after approval
|
Aug 13, 2024 |
|
Legal Minute: Do dietary supplements interact with drugs?
|
Aug 09, 2024 |
|
How Expert Pharma Marketers Navigate Privacy
|
Aug 07, 2024 |
|
Hiring New Employees in PharmaTech Companies
|
Aug 02, 2024 |
|
3 Hidden Dangers of Telehealth Marketing
|
Jul 29, 2024 |
|
Why a food lawyer would stop your restaurant’s marketing?
|
Jul 26, 2024 |
|
Legal Minute: Why are there chemo drug shortages?
|
Jul 24, 2024 |
|
Are Pharma Giants Ignoring Clinical Trial Site Issues?
|
Jul 22, 2024 |
|
Why Adverse Events Go Unreported in Clinical Trials
|
Jul 18, 2024 |
|
Who are patient advocates?
|
Jul 16, 2024 |
|
Why Drug Accountability Matters in Clinical Trials
|
Jul 11, 2024 |
|
Legal Minute: What do I do if my med is on shortage?
|
Jul 09, 2024 |
|
5 reasons not to use AI in creating pharma marketing content
|
Jul 07, 2024 |
|
8 essential elements of a valid prescription
|
Jul 06, 2024 |
|
No more lawyers in PRC?
|
Jul 04, 2024 |
|
Legal Minute: 4 Ways to Get Unapproved Drugs Legally!
|
Jul 02, 2024 |
|
The 4 Building Blocks of Using AI in any Pharma Marketing Strategy
|
Jun 27, 2024 |
|
Legal Minute: Why Clinical Trials Are Right for You!
|
Jun 26, 2024 |
|
Why Clinical Researchers Are Flocking to MedSpas
|
Jun 24, 2024 |
|
Legal Minute: Why You Should Never Trust a Celebrity with Your Health
|
Jun 18, 2024 |
|
Essential tips for pharmacy shutdowns
|
Jun 16, 2024 |
|
Why Clinical Researchers Are Flocking to MedSpas
|
Jun 14, 2024 |
|
Legal Minute: 5 Surprising Benefits of Ozempic!
|
Jun 11, 2024 |
|
Who Owns AI Generated Content in Pharma?
|
Jun 08, 2024 |
|
Legal Minute: Why does my drug cost so much?
|
Jun 07, 2024 |
|
AI for Promotions in FDA-Regulated Industries
|
Jun 06, 2024 |
|
Legal Minute: Billion-Dollar Speaker Scheme!
|
Jun 05, 2024 |
|
Off-Label Risks: Compliance Matters Now More Than Ever
|
Jun 03, 2024 |
|
6 Must-Knows Before Buying a Drug or Device Company
|
May 30, 2024 |
|
Legal Minute: Are there chemo drug shortages?
|
May 28, 2024 |
|
Legal Minute: Don’t Ignore State Registrations
|
May 24, 2024 |
|
Legal Minute: 6 Crucial Mistakes in Informed Consent
|
May 20, 2024 |
|
Legal Minute: What is informed consent in clinical trials?
|
May 16, 2024 |
|
Stop Risky Ads: Class Actions Could Cost You
|
May 13, 2024 |
|
Legal Minute: How do drugs work?
|
May 08, 2024 |
|
5 Surprising Causes of Life Science Deal Failures
|
May 03, 2024 |
|
Legal Minute: Is pharma bribing your doctor?
|
Apr 29, 2024 |
|
Legal Minute: Drug Registrations that can’t be ignored
|
Apr 23, 2024 |
|
Legal Minute: Why do pharmacies take so long to fill prescriptions?
|
Apr 19, 2024 |
|
Legal Minute: 3 Steps to Avoid Food Recalls
|
Apr 15, 2024 |
|
Legal Minute: Are dietary supplements as good as drugs?
|
Apr 12, 2024 |
|
Legal Minute: Clinical Trial Record Retention Disasters
|
Apr 08, 2024 |
|
Legal Minute: Why is your medicine so expensive?
|
Apr 04, 2024 |
|
McKinsey’s 2030 vision: A challenge for medical affairs
|
Apr 01, 2024 |
|
Legal Minute: 3 must-do takeaways for collecting diversity data in clinical trials
|
Mar 29, 2024 |
|
Legal Minute: Are Brand and Generic Drugs Truly Different?
|
Mar 23, 2024 |
|
Legal Minute: Who's REALLY Responsible for a Clinical Trial Congruency review?
|
Mar 18, 2024 |
|
This Drug Ad is FULL of Red Flags (We Expose Them All!)
|
Mar 13, 2024 |
|
7 ways to challenge FDA’s regulation of LDTs
|
Mar 09, 2024 |
|
Legal Minute: eBay’s $59 Million Drug-Making Problem
|
Mar 06, 2024 |
|
Legal Minute: Neuralink is a Game-Changer: 3 Lessons You Can't Afford to Miss
|
Mar 02, 2024 |
|
Legal Minute: Off-label marketing not ok again?
|
Feb 27, 2024 |
|
Don't Become the Next Fraud Headline: Lawyer Reveals Compliance Traps
|
Feb 25, 2024 |
|
Legal Minute: 3 Insider Secrets for a Successful Medical Device Recall
|
Feb 19, 2024 |
|
Key elements of a successful congruency review for clinical trial agreements
|
Feb 15, 2024 |
|
Why Private Equity firms are betting big on clinical research sites
|
Feb 12, 2024 |
|
5 Ways to Legally Share Off-Label Information
|
Feb 07, 2024 |
|
DOJ's "Get Out of Jail Free" card for pharma and device mergers?
|
Feb 04, 2024 |
|
Legal Minute: 5 factors to get your digital speaker program approved
|
Feb 01, 2024 |
|
Legal Minute: Decoding the FDA's prescription drug use related software guidance
|
Jan 30, 2024 |
|
Congruency Review: The Game Changer
|
Jan 28, 2024 |
|
Legal Minute: 5 hacks to fast-track your speaker program reviews
|
Jan 24, 2024 |
|
Selecting your ideal subject recruitment partner
|
Jan 22, 2024 |
|
Your digital sales team’s success depends on these 5 compliance rules
|
Jan 19, 2024 |
|
Legal Minute: 3 FTC rules for winning comparative claims
|
Jan 16, 2024 |
|
The risks and rewards of Clinical Research as a Care Option
|
Jan 14, 2024 |
|
3 game changing ways the FDA says AI will transform drug development
|
Jan 11, 2024 |
|
Legal Minute: Comparative claim review by NAD
|
Jan 10, 2024 |
|
5 foolproof ways to get your digital speaker program approved
|
Jan 05, 2024 |
|
Legal Minute: Prepare your Cosmetics Company for 2024
|
Jan 02, 2024 |
|
How to get PRC to approve your ads quickly
|
Dec 29, 2023 |
|
Legal Minute: 4 Must Do's When Choosing a Predicate Device for Your 510(k)
|
Dec 21, 2023 |
|
Legal Minute: FDA's Vision for the Future of IT
|
Dec 14, 2023 |
|
Legal Minute: FTC announces major revamp in 2024 enforcement strategy
|
Dec 10, 2023 |
|
23andMe data breach: Is your genetic data the next big target for hackers?
|
Dec 07, 2023 |
|
Ultimate Guide for Clinical Trial Publishing Rights in Large Academic Centers | Istvan Fekete
|
Dec 06, 2023 |
|
FDA's off-label trap: 7 reasons for uncertainty
|
Dec 04, 2023 |
|
Legal Minute: 3 ways #pharmacies are fighting high generic drug prices!
|
Dec 01, 2023 |
|
Pharma Industry Secrets: The Surprising Truth About DEI | Celia Daniels
|
Nov 24, 2023 |
|
Case Study: Academic Research Center Misconduct
|
Nov 15, 2023 |
|
Legal Minute: FTC Cracking Down on AI- 3 Must-Know Tips to Stay Compliant
|
Nov 11, 2023 |
|
Project management as a clinical research game-changer
|
Nov 05, 2023 |
|
Legal Minute: 5 Must-Do’s for Virginia Tech’s FBRI to combat research fraud
|
Oct 31, 2023 |
|
Legal Minute: Pharmacy Closing Checklist: 7 Must Do's
|
Oct 26, 2023 |
|
FDA Approval for LDTs Made Easy
|
Oct 22, 2023 |
|
Legal Minute: Pharmacist fraudster found guilty
|
Oct 19, 2023 |
|
AI's Complex Role: Creator, Copycat or Both?
|
Oct 15, 2023 |
|
FDA warns 8 companies including Walgreens selling unapproved eye products
|
Oct 10, 2023 |
|
Why the FDA’s plan to use one pagers will fail
|
Oct 05, 2023 |
|
Supercharge your Marketing Approval Process based on these Concept Review Tips
|
Oct 03, 2023 |
|
Testosterone parties and unapproved biohacks: Is it worth the risk? #darshantalks
|
Oct 01, 2023 |
|
Generative AI…confidently spews BS!
|
Sep 30, 2023 |
|
Testosterone parties and unapproved biohacks: Is it worth the risk? #darshantalks
|
Sep 28, 2023 |
|
Research Fraudster Banned by the FDA
|
Sep 28, 2023 |
|
How does CTP regulate tobacco? | Micah Berman
|
Sep 26, 2023 |
|
60 second reveal: 3 Regulatory authorities that can make or break your pharma or device sale
|
Sep 24, 2023 |
|
Maximizing FDA meetings: Getting the best out of every encounter | Ashley Preston
|
Sep 23, 2023 |
|
The role of decentralized trials in the traditional landscape | Isaac Rodriguez- Chavez
|
Sep 02, 2023 |
|
The Essential Guide to 7 Types of Clinical Trial Agreements
|
Aug 27, 2023 |